Hepatic stellate cell activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy

Journal of Hepatology

Volumn 26, Issue 3, 1997, Pages 584-592

  Ramm, Grant A ^a   Crawford, Darrell H G ^a   Powell, Lawrie W ^a   Walker, Neal I ^b   Fletcher, Linda M ^a   Halliday, June W ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

fat storing cell; hemochromatosis; hepatic fibrosis; iron; Ito cell; lipocyte; liver

Indexed keywords

ADULT; AGED; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; FEMALE; HEMOCHROMATOSIS; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; IRON BLOOD LEVEL; IRON OVERLOAD; LIVER BIOPSY; LIVER CELL; MAJOR CLINICAL STUDY; MALE; PHLEBOTOMY; PRIORITY JOURNAL; STEATOSIS; STELLATE CELL;

EID: 0031054425     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80424-2     Document Type: Article

References (46)

1. Simon M, Bourel M, Genetet B, Fauchet R. Idiopathic hemochromatosis: demonstration of recessive transmission and early detection by family HLA typing. N Engl J Med. 297:1977;1017-1021.
2. Leggett BA, Halliday JW, Brown NN, Bryant S, Powell LW. Prevalence of haemochromatosis amongst asymptomatic Australians. Br J Haematol. 74:1990;525-530.
3. Powell LW, Bassett ML, Halliday JW. Hemochromatosis 1980 update. Gastroenterology. 78:1980;374-381.
4. Nierderau C, Fisher R, Sonnenberg A, Stremmel W, Trammpisch HJ, Strohmeyer G. Survival and causes of death in cirrhotic and non-cirrhotic patients with primary hemochromatosis. N Engl J Med. 313:1985;1256-1262.
5. Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical level associated with fibrosis. Hepatology. 6:1986;24-29.
6. Friedman SL. Cellular sources of collagen and regulation of collagen production in liver. Semin Liver Dis. 10:1990;20-29.
7. Friedman SL. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med. 328:1993;1828-1835.
8. Maher JJ, McGuire RF. Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo. J Clin Invest. 86:1990;1641-1648.
9. Blomhoff R, Wake K. Perisinusoidal stellate cells of the liver: important roles in retinol metabolism and fibrosis. FASEB J. 5:1991;271-277.
10. Minato Y, Hasumura Y, Takeuchi J. The role of fat-storing cells in Disse space fibrogenesis in alcoholic liver disease. Hepatology. 3:1983;559-566.
11. Matsuoka M, Zhang MY, Tsukamoto H. Sensitization of hepatic lipocytes by high-fat diet to stimulatory effects of Kupffer cell-derived factors: implication in alcoholic liver fibrogenesis. Hepatology. 11:1990;173-182.
12. Ramm GA, Li SCY, Li L, Britton RS, O'Neill R, Kobayashi Y, Bacon BR. Chronic iron overload causes in vivo activation of rat lipocytes. Am J Physiol. 268:1995;G451-G458.
13. Pietrangelo A, Gualdi R, Casalgrandi G, Geerts A, De Bleser P, Montosi G, Ventura E. Enhanced hepatic collagen type I mRNA expression into fat-storing cells in a rodent model of hemochromatosis. Hepatology. 19:1994;714-721.
14. Rockey DC, Housset CN, Friedman SL. Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo. J Clin Invest. 92:1993;1795-1804.
15. 4- or vitamin A-treated rats. Dig Dis Sci. 32:1987;1281-1289.
16. Takahara T, Kojima T, Miyabayashi C, Inoue K, Sasaki H, Muragaki Y, Ooshima A. Collagen production in fat-storing cells after carbon tetrachloride intoxication in the rat: immunoelectron microscopic observation of type I, type III collagens, and prolyl hydroxylase. Lab Invest. 59:1988;509-521.
17. Hines JE, Johnson SJ, Burt AD. In vivo responses of macrophages and perisinusoidal cells to cholestatic liver injury. Am J Pathol. 142:1993;511-518.
18. Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology. 6:1986;24-29.
19. Schmitt-Graff A, Kruger A, Bochard F, Gabbiani G, Denk H. Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human liver. Am J Pathol. 138:1991;1233-1242.
20. Geerts A, De Bleser P, Hautekeete ML, Niki T, Wisse E. Fatstoring (Ito) cell biology. Arias IM, Boyer JL, Fausto N, Jakoby WB, Schachter D, Shafritz DA. The Liver: Biology and Pathobiology. 3rd edn. 1994;819-838 Raven Press, New York.
21. Sallie RW, Reed WD, Shilkin KB. Confirmation of the efficacy of hepatic tissue iron index in differentiating genetic haemochromatosis from alcoholic liver disease complicated by alcoholic haemosiderosis. Gut. 32:1991;207-210.
22. Pietrangelo A, Gualdi R, Casalgrandi G, Montosi G, Ventura E. Molecular and cellular aspects of iron-induced hepatic cirrhosis in rodents. J Clin Invest. 95:1995;1824-1831.
23. Gualdi R, Casalgrandi G, Montosi G, Ventura E, Pietrangelo A. Excess iron into hepatocytes is required for activation of collagen type I gene during experimental siderosis. Gastroenterology. 107:1994;1118-1124.
24. Stal P, Broome U, Scheynius A, Befrits R, Hultcrantz R. Kupffer cell iron overload induces intercellular adhesion molecule-1 on hepatocytes in genetic hemochromatosis. Hepatology. 21:1995;1308-1316.
25. Deugnier YM, Loreal O, Turlin B, Guyader D, Jouanolle H, Moirand R, Jacquelinet C, Brissot P. Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations. Gastroenterology. 102:1992;2050-2059.
26. Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology. 110:1996;1107-1119.
27. Cartwrightf GE, Edwards CQ, Kravitz K, Skolnick M, Amos DB, Johnson A, Buskjaer L. Hereditary hemochromatosis: phenotypic expression of the disease. N Engl J Med. 301:1979;175-179.
28. Guido M, Rugge M, Chemello L, Leandro G, Fattovich G, Giustina G, Cassaro M, Alberti A. Liver stellate cells in chronic viral hepatitis: the effect of interferon therapy. J Hepatol. 24:1996;301-307.
29. Baroni GS, Marucci L, Benedetti A, Mancini R, Jezequel A-M, Orlandi F. Chronic ethanol feeding increases apoptosis and cell proliferation in rat liver. J Hepatol. 20:1994;508-513.
30. Geerts A, Lazou J-M, De Bleser P, Wisse E. Tissue distribution, quantitation and proliferation kinetics of fat-storing cells in carbon tetrachloride-injured rat liver. Hepatology. 13:1991;1193-1202.
31. Horn T, Junge J, Christofferson P. Early alcoholic liver injury: activation of lipocytes in acinar zone 3 and correlation to degree of collagen formation in the disse space. J Hepatol. 3:1986;333-340.
32. Gressner AM, Bachem MG. Parasinusoidal lipocytes: their contribution to hepatic connective tissue synthesis and to the mechanisms of matrix amplification in fibrogenesis. Clement B, Guillouzo A. Cellular and Molecular Aspects of Cirrhosis. 1992;157-168 INSERM/J:Libbey, Paris.
33. Britton RS, O'Neill R, Bacon BR. Hepatic mitochondrial malondialdehyde metabolism in rats with chronic iron overload. Hepatol. 11:1990;93-97.
34. Brown KE, Kinter MT, Spitz DR, Savory J, Myers BM. Experimental iron overload is associated with increased levels of 4-hydroxynonenal, a toxic by-product of lipid peroxidation [Abstract]. Hepatology. 14:1991;159A.
35. Houglum K, Filip M, Witztum JL, Chojkier M. Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload. J Clin Invest. 86:1990;1991-1998.
36. Fletcher LM, Roberts FD, Irving MG, Powell LW, Halliday JW. Effects of ironloading on free radical scavenging enzymes and lipid peroxidation in rat liver. Gastroenterology. 97:1989;1011-1018.
37. Li L, O'Neill, Brown KE, Soweid AM, Britton RS, Poulos JE, Bacon BR. Vitamin E suppresses lipocyte activation in chronic iron overload [Abstract]. Hepatology. 22:1995;279A.
38. Parola M, Leonarduzzi G, Biasi F, Albano E, Biocca ME, Poli G, Dianzani MU. Vitamin E dietary supplementation protects against carbon tetrachloride-induced chronic liver damage and cirrhosis. Hepatology. 16:1992;1014-1021.
39. 1 gene expression in the liver. FEBS Letter. 308:1992;267-270.
40. Lee KS, Buck M, Houglum K, Chojkier M. Activation of hepatic stellate cells by TGFα and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest. 96:1995;2461-2468.
41. Gebhardt R. Metabolic zonation of the liver: regulation and implications for liver function. Pharmacol Ther. 53:1992;275-354.
42. Katz NR. Metabolic heterogeneity of hepatocytes across the liver acinus. J Nutr. 122:1992;843-849.
43. Wake K, Sato T. Intralobular heterogeneity of perisinusoidal stellate cells in porcine liver. Cell Tissue Res. 273:1993;227-237.
44. Zou Z, Ekataksin W, Kokubo Y, Wake K. Zonation alone cannot explain the functional heterogeneity of hepatic lobules: analysis of vitamin A storage in stellate cells of pig liver [Abstract]. Hepatology. 20:1994;210A.
45. Reid LM, Fiorino AS, Sigal SH, Brill S, Holst PA. Extracellular matrix gradients in the space of Disse: relevance to liver biology. Hepatology. 15:1992;1198-1203.
46. Sato T, Kato R, Tyson CA. Regulation of differentiated phenotype of rat hepatic lipocytes by retinoids in primary culture. Exp Cell Res. 217:1995;72-83.